FindTrial
Sign In

Results of micropulse cyclophotocoagulation in glaucoma patients who are not responding to other treatment modalities

Outcomes of micropulse cyclophotocoagulation in refractory glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055861
Enrollment
22
Registered
2023-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H408- Other glaucoma Health Condition 2: H408- Other glaucoma

Interventions

Intervention1: Micropulse cyclophotocoagulation: Procedure will be performed in the operating room with monitered anaesthesia care, we will be using Micropulse P3 device (Iridex, mountain view, CA) fo

Sponsors

Sankara Eye Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Refractory glaucoma not responding to IOP lowering medications, laser and previous glaucoma surgery.

Exclusion criteria

Exclusion criteria: 1. Active uveitis 2. Sclera thinning > 1 clock hours 3. Patients who are previously undergone cyclodestructive procedure for glaucoma

Design outcomes

Primary

MeasureTime frame
To assess efficacy of micropulse cyclophotocoagulation in refractory glaucomaTimepoint: IOP will be measured preoperatively and patient will be called for follow up after 1,3,6 months—

Secondary

MeasureTime frame
To evaluate safety of micropulse cyclophotocoagulation in refractory glaucoma which includes the number of adverse effects and complications occurred after treatmentTimepoint: IOP will be measured preoperatively and patient will be called for follow up after 1,3,6 months—

Countries

India

Contacts

Public ContactDr Pranoti Patil

Sankara eye hospital, Coimbatore

geeganesan@gmail.com9442016032

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026